Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Diarrhea × Colesevelam Hydrochloride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 2 Diarrhea 1 Breast Neoplasms 1

Interventions

Octreotide 2 telotristat ethyl 1 isatuximab 1 cabazitaxel 1 XRP6258 1 Prednisone 1 Leucovorin 1 Lapatinib 1 Irinotecan 1 Injections 1 Fluorouracil 1 Drugs, Investigational 1 Colesevelam Hydrochloride 1 Cell- and Tissue-Based Therapy 1 Capecitabine 1 Calcium Aluminosilicate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03767257 2025-10-21

A Study of Colesevelam for Lenalidomide-Associated Diarrhea

Memorial Sloan Kettering Cancer Center

Phase 2 Completed

25 enrolled 6 charts

Diarrhea, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡